C237-0233 Screening compound: N'-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N-[(furan-2-yl)methyl]butanediamide

C237-0233 Screening compound: N'-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N-[(furan-2-yl)methyl]butanediamide
C237-0233 Screening compound: N'-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N-[(furan-2-yl)methyl]butanediamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C237-0233
N'-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N-[(furan-2-yl)methyl]butanediamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C237-0233

Molecular Formula

C26H32N4O3 (C26 H32 N4 O3)

Compound Name

N'-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N-[(furan-2-yl)methyl]butanediamide

IUPAC name

N'-[2-(35-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N-[(furan-2-yl)methyl]butanediamide

SMILES

CC(CC(C)C1)CN1c1cc(C)c(cc(cc2)NC(CCC(NCc3ccco3)=O)=O)c2n1

InChI

InChI=1S/C26H32N4O3/c1-17-11-18(2)16-30(15-17)24-12-19(3)22-13-20(6-7-23(22)29-24)28-26(32)9-8-25(31)27-14-21-5-4-10-33-21/h4-7,10,12-13,17-18H,8-9,11,14-16H2,1-3H3,(H,27,31)(H,28,32)

InChI Key

BEYXWVAOMKNFQW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14733786

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.938

Distribution Coefficient, logD

4.938

Water Solubility, LogSw

-4.66

Polar Surface Area

66.450

Acid Dissociation Constant (pKa)

11.10

Base Dissociation Constant (pKb)

9.48

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

42.30

C237-0233 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with C237-0233 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C237-0233?
Check Price and Availability of C237-0233, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C237-0233 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C237-0233
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C237-0233
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C237-0233 available by request